Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anixa Biosciences ( (ANIX) ) has issued an update.
On March 20, 2025, Anixa Biosciences, Inc. held its annual meeting of stockholders, where 20,691,253 shares were represented. During the meeting, stockholders re-elected four directors, approved the executive compensation on a non-binding basis, ratified the appointment of Haskell & White LLP as the independent accounting firm for the fiscal year ending October 31, 2025, and decided on a one-year frequency for future advisory votes on executive compensation.
More about Anixa Biosciences
YTD Price Performance: 32.49%
Average Trading Volume: 113,324
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $98.2M
For a thorough assessment of ANIX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money